Pemoline (Cylert) for minimal brain dysfunction.
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D006128:Growth / Q000187:drug effects; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D010389:Pemoline / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos
D010919:Placebos; D008774:Methylphenidate; D010389:Pemoline; D003913:Dextroamphetamine